Login Register
Contact us

The Effects of Biosimilars and the Inflation Reduction Act on Prescription Drug Plans

May 16, 2024
2:00PM - 3:00PM ET



Employers Health is recognized by SHRM to offer Professional Development Credits (PDCs) for the SHRM-CP® or SHRM-SCP®. This program is valid for 1.0 PDCs for the SHRM-CP® or SHRM-SCP®.

The use of this seal confirms that this activity has met SHRM criteria for recertification credit pre-approval.

This program has been approved for 1.0 (HR (General)) recertification credit hour(s) toward aPHR™, aPHRi™, PHR®, PHRca®, SPHR®, GPHR®, PHRi™ and SPHRi™ recertification through the HR Certification Institute.

HR Certification Institute’s® ( official seal confirms that Employers Health meets the criteria for pre-approved recertification credit(s) for any of HRCI’s eight credentials, including SPHR® and PHR®.

About the Event

Hear from Jeff Casberg and Julie Kendle of IPD Analytics, as they share:

  • The status of launched biosimilars and anticipated developments in the biosimilar pipeline for 2024 and beyond.
  • Management strategies for unbranded biosimilars and PBM formulary exclusion lists.
  • How commercial employers and payers will be impacted by the prescription drug pricing provisions in the Inflation Reduction Act.

This presentation was previously recorded at the 2024 Annual Benefits Forum on March 6, 2024.